Equinom has secured $35 million in funding led by Synthesis Capital to accelerate the commercialization of its optimized, non-GMO plant protein ingredients for the growing plant-based food market.

Target Information

Equinom is a pioneering company focused on enhancing food production through the cultivation of optimized, non-GMO plant protein ingredients. By leveraging advanced technology, particularly its proprietary Manna™ platform, Equinom breeds new varieties of essential crops such as pea and soy, designed to require minimal processing. This innovation leads to improved taste, nutrition, and reduced costs, positioning Equinom as a vital player in the plant-based food sector.

Equinom's approach allows food manufacturers to create delicious, sustainable alternatives to traditional meat and dairy products. With this new funding, the company aims to accelerate the commercialization of its plant protein ingredients, targeting collaborations with multinational ingredient suppliers to streamline access for food companies.

Industry Overview

The plant-based food industry continues to experience significant growth, driven by consumer demand for healthier, more sustainable options. In India, where a large percentage of the population adheres to vegetarian diets, the